Status:
WITHDRAWN
QLESP Block in Hip Surgery
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Postoperative Pain
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Total hip arthroplasty (THA) is a common surgical procedure aiming to improve mobility and quality of life in patients suffering from hip pain. Regional analgesia techniques are critical components of...
Eligibility Criteria
Inclusion
- 1\. Age 18-65 yrs 2. American Society of Anesthesiologists classification 1-3 3. Body mass index between 20 and 35 (kg/m2) 4. Undergo elective primary unilateral THA via a posterolateral approach 5. Informed consent
Exclusion
- 1\. A known allergy to the drugs being used 2. Pre-existing neuropsychiatric disorders or language barrier 3. Analgesics intake, history of substance abuse 4. Contraindications to peripheral nerve block 5. Acute cerebrovascular disease 6. Severe liver failure
Key Trial Info
Start Date :
August 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05998954
Start Date
August 22 2023
End Date
October 20 2024
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wuhan Union Hospital
Wuhan, Hubei, China, 430022